Cargando…
Predictors of metformin monotherapy failure in gestational diabetes mellitus
OBJECTIVE: Metformin has emerged as a safe and effective pharmacological alternative to insulin in gestational diabetes mellitus (GDM), being associated with lower maternal weight gain and hypoglycemia risk. Nevertheless, glycemic control is unaccomplished in a considerable proportion of women only...
Autores principales: | Benido Silva, Vânia, Fonseca, Liliana, Pereira, Maria Teresa, Vilaverde, Joana, Pinto, Clara, Pichel, Fernando, Almeida, Maria do Céu, Dores, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175587/ https://www.ncbi.nlm.nih.gov/pubmed/35521811 http://dx.doi.org/10.1530/EC-21-0540 |
Ejemplares similares
-
Inappropriate gestational weight gain impact on maternofetal outcomes in gestational diabetes
por: Santos Monteiro, Sílvia, et al.
Publicado: (2022) -
Third trimester HbA1c and the association with large-for-gestational-age neonates in women with gestational diabetes
por: Fonseca, Liliana, et al.
Publicado: (2021) -
Six-Year Complete Remission of Type-1 Diabetes Mellitus in an Adult Treated With Sitagliptin
por: Benido Silva, Vânia, et al.
Publicado: (2023) -
Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014) -
Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)